May 30, 2020 | Publication & Research
Baricitinib, is an oral Janus kinase (JAK)1/JAK2 inhibitor approved for the treatment of rheumatoid arthritis (RA) that was independently predicted, using artificial intelligence (AI)-algorithms, to be useful for COVID-19 infection via a proposed anti-cytokine effects...
May 29, 2020 | Apps & DTx, Publication & Research
The increasing use of smartphones is accompanied by a significant increase in the use of mobile applications (apps). Chronically ill patients could permanently profit from this development.This development is fuelled by the Digital Healthcare Act (DVG), whereby...
May 22, 2020 | Online Lectures
Background: Social media websites are an important, largely untapped source of data about patients’ experience of living with disease and its treatment. This includes information on drugs such as the occurrence, nature and impact of side effects. However, there are...
May 17, 2020 | Online Lectures
We are very delighted to let you know that you are able to watch all lectures of the webinar online now! All three talks give you different insights into the topic: a global view, a tech approach and an “in the field” experience. Program 16:00 –...
